Description
Mechanism of Action:
✔ Metformin (500 mg ER): Decreases hepatic glucose production and enhances insulin sensitivity.
✔ Gliclazide (80 mg): Stimulates pancreatic beta cells to increase insulin release.
Indications:
✔ Type 2 Diabetes Mellitus
✔ Patients needing dual therapy for better glycemic control
Key Benefits:
✅ Dual mechanism for enhanced blood sugar regulation
✅ Reduces post-meal glucose spikes
✅ Extended-release formulation for prolonged action
Dosage & Administration:
- Recommended Dosage: One tablet daily or as prescribed.
- Route of Administration: Oral
- Food Intake: Take with food to minimize gastrointestinal discomfort.
Precautions & Warnings:
- Not suitable for Type 1 diabetes or diabetic ketoacidosis.
- Monitor kidney and liver function regularly.
- May cause hypoglycemia; avoid skipping meals.
Possible Side Effects:
- Hypoglycemia (low blood sugar)
- Nausea, bloating, or diarrhea
- Weight gain
Storage & Packaging:
- Store below 30°C in a cool, dry place.
- Available in blister packs and bulk packaging.
Manufacturing & Regulatory Compliance:
Manufactured by Aetos Life Care in WHO-GMP certified facilities, ensuring compliance with EU-GMP standards.
Global Export & Supply:
Aetos Life Care exports Metformin (ER) + Gliclazide Tablets 500 mg + 80 mg to Latin America, Africa, Asia, Europe, and CIS countries, providing cost-effective and high-quality diabetes management solutions worldwide.
